NeuroSense Therapeutics (NRSN) Receivables - Other (2020 - 2026)
NeuroSense Therapeutics (NRSN) posted Receivables - Other of $540,000 for Q2 2026, down 36.2% from $847,000 a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Receivables - Other (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics' Receivables - Other came in at $565,000, down 42.9% from FY2024.
- Annual Receivables - Other shows a five-year compound annual growth rate of 79.9% (FY2020 to FY2025).
- In prior years, NeuroSense Therapeutics' Receivables - Other was $989,000 in FY2024 (+319.1%), $236,000 in FY2023 (-7.5%), $255,000 in FY2022 (-17.7%) and $310,000 in FY2021 (+933.3%).
- The Q2 2026 figure stands as the lowest quarterly Receivables - Other since Q3 2024.
- On a year-over-year basis, Receivables - Other increased in three of the last five quarters, with growth averaging 79.3%.
- The strongest year-over-year quarter for Receivables - Other in the past five years was Q4 2024, with growth of 319.1%; the weakest was Q4 2025, with a decline of 42.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | NeuroSense Therapeutics | 3.19 Mn | -1.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 540,000.00 |
| Dec 31, 2025 | 565,000.00 |
| Jun 30, 2025 | 847,000.00 |
| Dec 31, 2024 | 989,000.00 |
| Sep 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 376,000.00 |
| Mar 31, 2024 | 421,000.00 |
| Dec 31, 2023 | 236,000.00 |
| Sep 30, 2023 | 309,000.00 |
| Jun 30, 2023 | 434,000.00 |
| Mar 31, 2023 | 567,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 425,000.00 |
| Jun 30, 2022 | 707,000.00 |
| Mar 31, 2022 | 225,000.00 |
| Dec 31, 2021 | 76,000.00 |
| Dec 31, 2020 | 30,000.00 |
API Access
NeuroSense Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();